Androgen receptor-directed therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Androgen receptor-directed therapy, covering 2025-10-09 to 2025-10-09. Get the full timeline:
Most recent: Clinical Trial Update: 177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer [Phase 3]